Suchergebnisse - "Blodi, Barbara"
-
1
AI-based monitoring of retinal fluid in disease activity and under therapy
ISSN: 1350-9462, 1873-1635, 1873-1635Veröffentlicht: England Elsevier Ltd 01.01.2022Veröffentlicht in Progress in retinal and eye research (01.01.2022)“… Retinal fluid as the major biomarker in exudative macular disease is accurately visualized by high-resolution three-dimensional optical coherence tomography …”
Volltext
Journal Article -
2
Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials
ISSN: 1549-4713, 1549-4713Veröffentlicht: United States 01.01.2014Veröffentlicht in Ophthalmology (Rochester, Minn.) (01.01.2014)“… To describe risk factors for geographic atrophy (GA) in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Cohort within a randomized …”
Weitere Angaben
Journal Article -
3
Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3
ISSN: 1549-4713, 1549-4713Veröffentlicht: United States 01.04.2018Veröffentlicht in Ophthalmology (Rochester, Minn.) (01.04.2018)“… To develop consensus terminology and criteria for defining atrophy based on OCT findings in the setting of age-related macular degeneration (AMD). Consensus …”
Weitere Angaben
Journal Article -
4
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
ISSN: 2168-6173, 2168-6173Veröffentlicht: United States 01.07.2021Veröffentlicht in JAMA ophthalmology (01.07.2021)“… The role of anti-vascular endothelial growth factor injections for the management of nonproliferative diabetic retinopathy (NPDR) without center-involved …”
Weitere Angaben
Journal Article -
5
Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4
ISSN: 1549-4713, 1549-4713Veröffentlicht: United States 01.03.2020Veröffentlicht in Ophthalmology (Rochester, Minn.) (01.03.2020)“… To describe the defining features of incomplete retinal pigment epithelium (RPE) and outer retinal atrophy (iRORA), a consensus term referring to the OCT-based …”
Weitere Angaben
Journal Article -
6
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial
ISSN: 1538-3598, 1538-3598Veröffentlicht: United States 23.05.2017Veröffentlicht in JAMA : the journal of the American Medical Association (23.05.2017)“… Studies have established the efficacy and safety of aflibercept for the treatment of macular edema due to central retinal vein occlusion. Bevacizumab is used …”
Weitere Angaben
Journal Article -
7
Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials
ISSN: 1549-4713, 1549-4713Veröffentlicht: United States 01.03.2011Veröffentlicht in Ophthalmology (Rochester, Minn.) (01.03.2011)“… To investigate the cause of visual acuity (VA) loss in patients with neovascular age-related macular degeneration (AMD) receiving monthly ranibizumab …”
Weitere Angaben
Journal Article -
8
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab
ISSN: 2168-6173, 2168-6173Veröffentlicht: United States 01.06.2017Veröffentlicht in JAMA ophthalmology (01.06.2017)“… Anti-vascular endothelial growth factor (anti-VEGF) therapy for diabetic macular edema (DME) favorably affects diabetic retinopathy (DR) improvement and …”
Weitere Angaben
Journal Article -
9
Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings
ISSN: 1549-4713, 1549-4713Veröffentlicht: United States 01.04.2017Veröffentlicht in Ophthalmology (Rochester, Minn.) (01.04.2017)“… To summarize the results of 2 consensus meetings (Classification of Atrophy Meeting [CAM]) on conventional and advanced imaging modalities used to detect and …”
Weitere Angaben
Journal Article -
10
Photoreceptor assessment in age-related macular degeneration
ISSN: 1476-5454, 1476-5454Veröffentlicht: England 01.02.2025Veröffentlicht in Eye (London) (01.02.2025)“… Clinical trials investigating drugs for various stages of age-related macular degeneration (AMD) are actively underway and there is a strong interest in …”
Weitere Angaben
Journal Article -
11
Longitudinal Assessment of Age-Related Macular Degeneration Using Ultrawidefield Imaging: The Optos Peripheral Retina Follow-up Study
ISSN: 1549-4713Veröffentlicht: United States 01.05.2025Veröffentlicht in Ophthalmology (Rochester, Minn.) (01.05.2025)“… With the widespread availability of Ultrawidefield (UWF) imaging, peripheral retinal abnormalities in age-related macular degeneration (AMD) have garnered …”
Weitere Angaben
Journal Article -
12
Thrombospondin-1, BIM and CFH polymorphisms and response to anti-VEGF treatment in neovascular age- related macular degeneration patients
ISSN: 1932-6203, 1932-6203Veröffentlicht: United States Public Library of Science 26.02.2024Veröffentlicht in PloS one (26.02.2024)“… Age-related macular degeneration (AMD) is a vision threatening disease in older adults. Anti-VEGF treatment is effective for the majority of neovascular AMD …”
Volltext
Journal Article -
13
SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion
ISSN: 1549-4713, 1549-4713Veröffentlicht: United States 01.10.2023Veröffentlicht in Ophthalmology (Rochester, Minn.) (01.10.2023)“… To investigate whether a nonlinear association between central subfield thickness (CST) on spectral-domain OCT and concurrent visual acuity letter score (VALS) …”
Weitere Angaben
Journal Article -
14
A semi-automated machine-learning based workflow for ellipsoid zone analysis in eyes with macular edema: SCORE2 pilot study
ISSN: 1932-6203, 1932-6203Veröffentlicht: United States Public Library of Science 30.04.2020Veröffentlicht in PloS one (30.04.2020)“… To develop a semi-automated, machine-learning based workflow to evaluate the ellipsoid zone (EZ) assessed by spectral domain optical coherence tomography …”
Volltext
Journal Article -
15
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3
ISSN: 2168-6173, 2168-6173Veröffentlicht: United States 01.02.2014Veröffentlicht in JAMA ophthalmology (01.02.2014)“… The Age-Related Eye Disease Study (AREDS) formulation for the treatment of age-related macular degeneration (AMD) contains vitamin C, vitamin E, beta carotene, …”
Weitere Angaben
Journal Article -
16
Foundational Considerations for Artificial Intelligence Using Ophthalmic Images
ISSN: 1549-4713, 1549-4713Veröffentlicht: United States 01.02.2022Veröffentlicht in Ophthalmology (Rochester, Minn.) (01.02.2022)“… The development of artificial intelligence (AI) and other machine diagnostic systems, also known as software as a medical device, and its recent introduction …”
Weitere Angaben
Journal Article -
17
Association of Retinal Thickness at Month 1 Postrandomization With Later Thickness and Visual Acuity in Central Vein Occlusion
ISSN: 0002-9394, 1879-1891, 1879-1891Veröffentlicht: United States Elsevier Inc 01.10.2024Veröffentlicht in American journal of ophthalmology (01.10.2024)“… To investigate the association of retinal thickness 1 month after the first study aflibercept or bevacizumab injection with later retinal thickness, visual …”
Volltext
Journal Article -
18
Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration
ISSN: 1549-4713, 1549-4713Veröffentlicht: United States 01.10.2007Veröffentlicht in Ophthalmology (Rochester, Minn.) (01.10.2007)“… To assess pharmacodynamic responses to ranibizumab, an inhibitor of vascular endothelial growth factor A (VEGF-A), in a study of the treatment of minimally …”
Weitere Angaben
Journal Article -
19
Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion
ISSN: 0002-9394, 1879-1891, 1879-1891Veröffentlicht: United States Elsevier Inc 01.08.2022Veröffentlicht in American journal of ophthalmology (01.08.2022)“… To investigate 5-year outcomes in eyes initially treated with aflibercept or bevacizumab for macular edema due to central retinal or hemiretinal vein …”
Volltext
Journal Article -
20
Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion
ISSN: 0002-9394, 1879-1891, 1879-1891Veröffentlicht: United States Elsevier Inc 01.04.2024Veröffentlicht in American journal of ophthalmology (01.04.2024)“… To evaluate imaging findings from SCORE2 participants through 60 months, to describe the degree of resolution or progression of these variables, and to …”
Volltext
Journal Article